Endpoints for lymphatic filariasis programs

Caroline A. Grady, Madsen Beau De Rochars, Abdel N. Direny, Jean Nicolas Orelus, Joyanna Wendt, Jeanne Radday, Els Mathieu, Jacquelin M. Roberts, Thomas G. Streit, David G. Addiss, Patrick J. Lammie

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs.

Original languageEnglish (US)
Pages (from-to)608-610
Number of pages3
JournalEmerging infectious diseases
Issue number4
StatePublished - Apr 2007
Externally publishedYes

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Endpoints for lymphatic filariasis programs'. Together they form a unique fingerprint.

Cite this